178 related articles for article (PubMed ID: 37216728)
21. Detection of familial hypercholesterolemia in patients from a general practice database.
Casula M; Catapano AL; Rossi Bernardi L; Visconti M; Aronica A
Atheroscler Suppl; 2017 Oct; 29():25-30. PubMed ID: 28965617
[TBL] [Abstract][Full Text] [Related]
22. Low-density lipoprotein cholesterol goal attainment in patients with clinical evidence of familial hypercholesterolemia and elevated Lp(a).
Schwarz A; Demuth I; Landmesser U; Haghikia A; König M; Steinhagen-Thiessen E
Lipids Health Dis; 2022 Nov; 21(1):114. PubMed ID: 36324160
[TBL] [Abstract][Full Text] [Related]
23. Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.
Alhabib KF; Al-Rasadi K; Almigbal TH; Batais MA; Al-Zakwani I; Al-Allaf FA; Al-Waili K; Zadjali F; Alghamdi M; Alnouri F; Awan Z; Kinsara AJ; AlQudaimi A; Almahmeed W; Sabbour H; Traina M; Atallah B; Al-Jarallah M; AlSarraf A; AlSayed N; Amin H; Altaradi H
PLoS One; 2021; 16(6):e0251560. PubMed ID: 34086694
[TBL] [Abstract][Full Text] [Related]
24. Gaps in the Care of Subjects with Familial Hypercholesterolemia: Insights from the Thai Familial Hypercholesterolemia Registry.
Ganokroj P; Muanpetch S; Deerochanawong C; Phimphilai M; Leelawattana R; Thongtang N; Krittayaphong R; Anthanont P; Vathesatogkit P; Sriphrapradang C; Senthong V; Torpongpun A; Suteerayongprasert P; Pengpong N; Sathavarodom N; Sunanta U; Porntharukchareon T; Kiatpanabhikul P; Kaewkrasaesin C; Suraamornkul S; Kongkit J; Umphonsathien M; Chattranukulchai P; Jiamjarasrungsi W; Khovidhunkit W
J Atheroscler Thromb; 2023 Dec; 30(12):1803-1816. PubMed ID: 37197952
[TBL] [Abstract][Full Text] [Related]
25. Familial hypercholesterolemia and cardiovascular disease in older individuals.
Coutinho ER; Miname MH; Rocha VZ; Bittencourt MS; Jannes CE; Tada MT; Lima IR; Filho WS; Chacra AP; Pereira AC; Krieger JE; Santos RD
Atherosclerosis; 2021 Feb; 318():32-37. PubMed ID: 33450476
[TBL] [Abstract][Full Text] [Related]
26. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.
Singh A; Gupta A; Collins BL; Qamar A; Monda KL; Biery D; Lopez JAG; de Ferranti SD; Plutzky J; Cannon CP; Januzzi JL; Di Carli MF; Nasir K; Bhatt DL; Blankstein R
J Am Coll Cardiol; 2019 May; 73(19):2439-2450. PubMed ID: 31097165
[TBL] [Abstract][Full Text] [Related]
27. Rapid identification of familial hypercholesterolemia from electronic health records: The SEARCH study.
Safarova MS; Liu H; Kullo IJ
J Clin Lipidol; 2016; 10(5):1230-9. PubMed ID: 27678441
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART).
Mata N; Alonso R; Badimón L; Padró T; Fuentes F; Muñiz O; Perez-Jiménez F; López-Miranda J; Díaz JL; Vidal JI; Barba A; Piedecausa M; Sanchez JF; Irigoyen L; Guallar E; Ordovas JM; Mata P
Lipids Health Dis; 2011 Jun; 10():94. PubMed ID: 21663647
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN
Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064
[TBL] [Abstract][Full Text] [Related]
30. Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.
Saltijeral A; Pérez de Isla L; Alonso R; Muñiz O; Díaz-Díaz JL; Fuentes F; Mata N; de Andrés R; Díaz-Soto G; Pastor J; Pinilla JM; Zambón D; Pinto X; Badimón L; Mata P;
Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):444-450. PubMed ID: 27913073
[TBL] [Abstract][Full Text] [Related]
31. The rationale and design of the national familial hypercholesterolemia registries in Turkey: A-HIT1 and A-HIT2 studies.
Kayıkçıoğlu M; Tokgözoğlu L
Turk Kardiyol Dern Ars; 2017 Apr; 45(3):261-267. PubMed ID: 28429694
[TBL] [Abstract][Full Text] [Related]
32. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice.
Catapano AL; Lautsch D; Tokgözoglu L; Ferrieres J; Horack M; Farnier M; Toth PP; Brudi P; Tomassini JE; Ambegaonkar B; Gitt AK
Atherosclerosis; 2016 Sep; 252():1-8. PubMed ID: 27494444
[TBL] [Abstract][Full Text] [Related]
34. The effects of 3-year statin therapy and the achievement of LDL cholesterol target values in familial hypercholesterolemia patients: An experience from Serbia.
Lalić K; Rajković N; Popović L; Lukač SS; Stošić L; Rasulić I; Lalić NM
Atherosclerosis; 2018 Oct; 277():298-303. PubMed ID: 30270062
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.
De Luca L; Arca M; Temporelli PL; Colivicchi F; Gonzini L; Lucci D; Bosco B; Callerame M; Lettica GV; Di Lenarda A; Gulizia MM;
Clin Cardiol; 2018 Aug; 41(8):1075-1083. PubMed ID: 30039543
[TBL] [Abstract][Full Text] [Related]
37. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
Nordestgaard BG; Chapman MJ; Humphries SE; Ginsberg HN; Masana L; Descamps OS; Wiklund O; Hegele RA; Raal FJ; Defesche JC; Wiegman A; Santos RD; Watts GF; Parhofer KG; Hovingh GK; Kovanen PT; Boileau C; Averna M; Borén J; Bruckert E; Catapano AL; Kuivenhoven JA; Pajukanta P; Ray K; Stalenhoef AF; Stroes E; Taskinen MR; Tybjærg-Hansen A;
Eur Heart J; 2013 Dec; 34(45):3478-90a. PubMed ID: 23956253
[TBL] [Abstract][Full Text] [Related]
38. Familial Hypercholesterolemia: Global Burden and Approaches.
Tokgozoglu L; Kayikcioglu M
Curr Cardiol Rep; 2021 Sep; 23(10):151. PubMed ID: 34480646
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular risk factor profiles in familial hypercholesterolemia patients with and without genetic mutation compared to a nationally representative sample of adults in a high-risk European country.
Chlebus K; Zdrojewski T; Gruchała M; Gałąska R; Pajkowski M; Kocejko MR; Chmara M; Pencina MJ
Am Heart J; 2019 Dec; 218():32-45. PubMed ID: 31706143
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
